In the last week, the Australian market has stayed flat, yet it is up 14% over the past year with earnings forecasted to grow by 12% annually. In this context of steady growth and positive earnings outlook, identifying undervalued stocks can offer potential opportunities for investors seeking to capitalize on market inefficiencies.

Top 10 Undervalued Stocks Based On Cash Flows In Australia

Name Current Price Fair Value (Est) Discount (Est) Wrkr (ASX:WRK) A$0.115 A$0.20 42.5% Temple & Webster Group (ASX:TPW) A$6.60 A$12.14 45.6% SiteMinder (ASX:SDR) A$3.18 A$5.66 43.8% ReadyTech Holdings (ASX:RDY) A$1.39 A$2.47 43.7% Nuix (ASX:NXL) A$1.30 A$2.48 47.5% Magellan Financial Group (ASX:MFG) A$9.73 A$17.59 44.7% LGI (ASX:LGI) A$3.65 A$6.99 47.8% Judo Capital Holdings (ASX:JDO) A$1.36 A$2.58 47.2% Genesis Minerals (ASX:GMD) A$6.61 A$12.83 48.5% Cogstate (ASX:CGS) A$2.43 A$4.71 48.4%

Click here to see the full list of 43 stocks from our Undervalued ASX Stocks Based On Cash Flows screener.

We're going to check out a few of the best picks from our screener tool.

Cochlear

Overview: Cochlear Limited develops and supplies implantable hearing solutions for children and adults globally, with a market cap of A$6.51 billion.

Operations: The company's revenue primarily comes from its Implantable Hearing Device segment, totaling A$2.34 billion.

Estimated Discount To Fair Value: 34%

Cochlear Limited appears undervalued, trading at A$99.58, significantly below its estimated future cash flow value of A$150.95. Despite a slight decline in recent net income to A$161.5 million, earnings are forecast to grow 14.1% annually, outpacing the Australian market's 12.3%. However, its dividend yield of 4.32% isn't well covered by free cash flows, which may be a concern for sustainability despite being franked at 85%.

In light of our recent growth report, it seems possible that Cochlear's financial performance will exceed current levels. Click here and access our complete balance sheet health report to understand the dynamics of Cochlear.ASX:COH Discounted Cash Flow as at Apr 2026

Elsight

Overview: Elsight Limited develops and commercializes connectivity solutions across Europe, Israel, the United States, and internationally, with a market cap of A$1.53 billion.

Operations: The company's revenue primarily stems from its electronic security devices segment, generating $22.80 million.

Estimated Discount To Fair Value: 40.8%

Elsight Limited is trading at A$6.92, significantly below its estimated future cash flow value of A$11.7, suggesting it may be undervalued based on cash flows. The company recently reported a substantial increase in sales to US$22.8 million and net income of US$7.48 million for 2025, marking a turnaround from the previous year's loss. Earnings are forecast to grow 51.4% annually, surpassing market expectations and supporting its growth narrative in defense and government markets.

Story Continues

Our expertly prepared growth report on Elsight implies its future financial outlook may be stronger than recent results. Get an in-depth perspective on Elsight's balance sheet by reading our health report here.ASX:ELS Discounted Cash Flow as at Apr 2026

Genesis Minerals

Overview: Genesis Minerals Limited is involved in gold mining, project development, and exploration activities in Western Australia with a market cap of A$7.55 billion.

Operations: The company generates revenue from mineral production, exploration, and development activities amounting to A$1.40 billion.

Estimated Discount To Fair Value: 48.5%

Genesis Minerals is trading at A$6.61, well below its estimated future cash flow value of A$12.83, highlighting potential undervaluation based on cash flows. The company reported a significant increase in sales to A$820.35 million and net income of A$238.04 million for the half year ending December 2025, with earnings per share also rising sharply from the previous year. Recent management restructuring aims to drive growth and operational efficiency as Genesis expands its gold production capabilities.

The analysis detailed in our Genesis Minerals growth report hints at robust future financial performance. Click to explore a detailed breakdown of our findings in Genesis Minerals' balance sheet health report.ASX:GMD Discounted Cash Flow as at Apr 2026

Key Takeaways

Navigate through the entire inventory of 43 Undervalued ASX Stocks Based On Cash Flows here. Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools. Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.

Seeking Other Investments?

Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ASX:COH ASX:ELS and ASX:GMD.

This article was originally published by Simply Wall St.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments